Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125507721 | 12550772 | 1 | I | 20160317 | 20160712 | 20160712 | PER | US-APOTEX-2016AP007297 | APOTEX | 83.00 | YR | F | Y | 0.00000 | 20160712 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125507721 | 12550772 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, QD | U | 76274 | 75 | MG | TABLET | ||||||
| 125507721 | 12550772 | 2 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 325 MG, QD | U | 0 | 325 | MG | |||||||
| 125507721 | 12550772 | 3 | SS | ASPIRIN /00002701/ | ASPIRIN | 1 | Unknown | 75-325 MG/DAY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125507721 | 12550772 | 1 | Antiplatelet therapy |
| 125507721 | 12550772 | 2 | Antiplatelet therapy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125507721 | 12550772 | Epistaxis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |